Skip to Main Content

Real-Time Surveillance of E-Cigarette, or Vaping, Product-Use Associated Lung Injury (EVALI)

Conditions

Addictive Behaviors | Tobacco Addiction | COVID-19 Inpatient | COVID-19 Outpatient

Phase COVID-Pilot

What is the purpose of this trial?

The purpose of our research study is to advance our understanding of risk factors for acute illness among people who use vaping or smoking products. Participation in this study will involve surveys, analysis of e-liquids (if used), and analysis of blood and urine. Research staff will collect some information about your demographics, personal history, and lab results to understand more about you and identify risk factors for health problems. Research staff would also like to analyze a sample of any e-liquids recently used. You will receive up to $50 for taking part in this study: $20 for competition of the surveys and an additional $30 if you provide small samples of e-liquids that you recently used.

  • Trial with
    National Institute on Drug Abuse/NIH/DHHS
  • Start Date
    02/28/2020
  • End Date
    02/28/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000027263